7 results match your criteria: "From the McMaster University[Affiliation]"
A Case Report: PSMA PET/CT in Retroperitoneal Hemangioma.
Clin Nucl Med
January 2025
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Article Synopsis
- * This patient had a rising PSA level prompting a PSMA PET/CT scan, which revealed a suspicious lesion in the retroperitoneum.
- * Upon further testing, the lesion was identified as a retroperitoneal hemangioma, highlighting the complexities of interpreting PET/CT results in prostate cancer and the need for careful diagnosis.
Progress in Applied Research on the Laboratory Diagnosis of Sexually Transmitted Diseases and the Role of the STD Journal.
Sex Transm Dis
September 2024
From the McMaster University, Hamilton, Ontario, Canada.
A practical focus on fish and shellfish oral immunotherapy.
J Food Allergy
July 2022
Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Although fish and shellfish allergies represent common worldwide allergies, with anaphylaxis being reportedly frequent, treatment approaches, e.g., oral immunotherapy (OIT), are uncommonly performed.
View Article and Find Full Text PDFUltrasound-Guided Interventions in Lateral Epicondylitis.
J Clin Rheumatol
April 2019
From the McMaster University, Hamilton, Ontario, Canada.
Lateral epicondylitis is a painful condition related to the myotendinous origin of the extensor muscles at the lateral epicondyle of the humerus. Primary treatment typically involves the use of rest, non-steroidal anti-inflammatory drugs (NSAIDs), and physiotherapy. However, in refractory cases where conventional therapy is ineffective, ultrasound-guided injection therapies have become a growing form of treatment.
View Article and Find Full Text PDFCirculating biomarkers and incident ischemic stroke in the Framingham Offspring Study.
Neurology
September 2016
From the McMaster University and Population Health Research Institute (A.S.), Hamilton, Canada; Boston University School of Public Health (S.R.P., A.S.B., E.J.B.), Boston; and Boston University School of Medicine (A.S., A.S.B., C.S.K., P.A.W., R.S.V., E.J.B., S.S., J.R.R.), Boston, MA.
Objective: We related a panel of inflammatory biomarkers to risk of incident ischemic stroke (IIS) in a community-dwelling sample.
Methods: Stroke-free Framingham offspring attending examination cycle 7 (1998-2001) had 15 circulating inflammatory biomarkers measured. Cox proportional hazard models were used to calculate the hazard ratios (HRs) of IIS per SD increment of each biomarker.
Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial.
Stroke
October 2013
From the McMaster University, Hamilton, Ontario, Canada (K.K.T.); Duke University and Durham VA Medical Center, Durham, NC (L.B.G.); St. Louis University, St. Louis, MO (B.R.C., S.C.-F.); Axio Research LLC, Seattle, WA (S.G.); Christiana Care Health Services, Newark, DE (W.S.W.); University of Minnesota, Minneapolis, MN (D.C.A.); Case Western Reserve University School of Medicine, Cleveland, OH (C.A.S.); AbbVie, North Chicago, IL (R.J.P.); LHSC University Hospital, London, Ontario, Canada (W.J.K.); and Samuel S. Stratton VA Medical Center, Albany Medical Center and Albany Medical College, Albany, NY (W.E.B.).
Background And Purpose: In Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcomes (AIM-HIGH) trial, addition of extended-release niacin (ERN) to simvastatin in participants with established cardiovascular disease, low high-density lipoprotein cholesterol, and high triglycerides had no incremental benefit, despite increases in high-density lipoprotein cholesterol. Preliminary analysis based on incomplete end point adjudication suggested increased ischemic stroke risk among participants randomized to ERN.
Methods: This final analysis was conducted after complete AIM-HIGH event ascertainment to further explore potential relationship between niacin therapy and ischemic stroke risk.